Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin E Morales

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Urology|October 12, 2015
Natural Compounds Targeting STAT3 Mediated InflammationEdwin E Morales, Bharat B Aggarwal, Ashish M Kamat
Apoptosis : an International Journal on Programmed Cell Death|September 22, 2016
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacksGoodwin G Jinesh, Sharada Mokkapati, Keyi Zhu, et al.
The Journal of Bone and Joint Surgery. American Volume|April 3, 2010
Use of medical comorbidities to predict complications after hip fracture surgery in the elderlyDerek J Donegan, A Nicolas Gay, Keith Baldwin, et al.
European Urology|September 1, 2015
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEdwin E Morales, Sonja Grill, Robert S Svatek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trialRobert S Svatek, Xiang Ru Zhao, Edwin E Morales, et al.
Urologic Oncology|June 26, 2017
Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatmentStephen B Williams, Jinhai Huo, Tamer J Dafashy, et al.
Oncoimmunology|August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trialNiannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Urology|October 12, 2015
Natural Compounds Targeting STAT3 Mediated InflammationEdwin E Morales, Bharat B Aggarwal, Ashish M Kamat
Apoptosis : an International Journal on Programmed Cell Death|September 22, 2016
Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacksGoodwin G Jinesh, Sharada Mokkapati, Keyi Zhu, et al.
The Journal of Bone and Joint Surgery. American Volume|April 3, 2010
Use of medical comorbidities to predict complications after hip fracture surgery in the elderlyDerek J Donegan, A Nicolas Gay, Keith Baldwin, et al.
European Urology|September 1, 2015
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening StudyEdwin E Morales, Sonja Grill, Robert S Svatek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trialRobert S Svatek, Xiang Ru Zhao, Edwin E Morales, et al.
Urologic Oncology|June 26, 2017
Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatmentStephen B Williams, Jinhai Huo, Tamer J Dafashy, et al.
Oncoimmunology|August 16, 2019
Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trialNiannian Ji, Neelam Mukherjee, Edwin E Morales, et al.
Pageof 1